Introduction
Next-generation sequencing (NGS) in Clinical Mycology is revolutionizing the diagnosis, typing, and antifungal resistance profiling of fungal pathogens.
Application
Here’s an overview of its applications:
- Pathogen Identification-NGS can identify fungal species with high precision, including rare and emerging pathogens that are difficult to detect using conventional methods.
- Whole Genome Sequencing (WGS): Identifies fungal species based on entire genomes.
- Targeted Sequencing (e.g., ITS, 18S rRNA): Amplifies specific fungal genomic regions for species-level identification.
- Metagenomics: Enables detection of fungi in mixed microbial communities directly from clinical specimens without culture.
- Antifungal Resistance Detection-NGS can identify genetic mutations associated with resistance to antifungal drugs, such as:
Candida spp.:
- CDR1, CDR2: Efflux pumps contribute to azole resistance.
- ERG11: Azole resistance due to mutations in ergosterol synthesis.
- FKS1, FKS2: Echinocandin resistance (glucan synthase mutations).
Aspergillus spp.: CYP51A: Azole resistance due to mutations in ergosterol synthesis.
- Epidemiological Studies and Outbreak Investigations-NGS is instrumental in understanding the spread of fungal infections within healthcare settings by:
- Comparing genomic sequences of fungal isolates to identify sources of infection.
- Tracking the evolution of multidrug-resistant fungal strains.
- Study of Host-Fungal Interactions-Transcriptomic and metatranscriptomic studies (RNA sequencing) provide insights into:
- Host immune responses to fungal infections.
- Mechanisms by which fungi evade immune defenses.
- Fungal Microbiome Analysis-NGS facilitates the study of the fungal microbiota (mycobiome) in various clinical conditions, such as:
- Pulmonary aspergillosis.
- Gastrointestinal and systemic fungal infections.
- Dermatological conditions caused by dermatophytes.
- Detection of Polymicrobial Infections-NGS can detect co-infections involving fungi and bacteria or viruses in complex clinical specimens, guiding more effective treatment strategies.
- The Discovery of New Fungal Species- NGS enables the discovery and characterization of novel fungal species, improving our understanding of fungal biodiversity and its clinical relevance.
- Functional Genomics and Proteomics-NGS supports functional studies of fungal genes and proteins, which can lead to:
- Identification of virulence factors.
- Discovery of novel therapeutic targets.
Advantages of NGS in Clinical Mycology
- Culture-independent identification.
- High sensitivity for detecting low fungal loads.
- Simultaneous detection of multiple fungal species.
- Comprehensive profiling of antifungal resistance.
Challenges
- High costs and technical expertise required.
- Interpretation of results requires bioinformatics tools and databases.
- Limited standardization for clinical application.
Keynote
NGS has immense potential to advance clinical mycology by improving diagnostic accuracy, understanding antifungal resistance, and guiding personalized treatment approaches for fungal infections.